Pantoprazole Sodium Injection, Powder, Lyophilized, For Solution
FDA Label NDC 55154-7477

44 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Pantoprazole Sodium (NDC 55154-7477). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1  gastroesophageal reflux disease associated with a history of erosive esophagitis, 1.2  pathological hypersecretion including zollinger-ellison syndrome, 2.1  dosage for gastroesophageal reflux disease associated with a history of erosive esophagitis, 2.2  preparation and administration instructions for gastroesophageal reflux disease associated with a history of erosive esophagitis, 2.3  dosage for pathological hypersecretion including zollinger-ellison syndrome, 2.4  preparation and administration instructions for pathological hypersecretion including zollinger-ellison syndrome, 2.5  compatibility information, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

NDC 55154-7477-5

PANTOPRAZOLE SODIUM

FOR INJECTION

Equivalent to pantoprazole

40 mg per vial

5 VIALS

40mg Per Vial Bag Label (284915b9 082e 4c76 8998 13aff7221045 00)

40mg Per Vial Bag Label (284915b9 082e 4c76 8998 13aff7221045 00)

* Please review the disclaimer below.